IL155506A0 - Process for folding chemically synthesized polypeptides - Google Patents

Process for folding chemically synthesized polypeptides

Info

Publication number
IL155506A0
IL155506A0 IL15550601A IL15550601A IL155506A0 IL 155506 A0 IL155506 A0 IL 155506A0 IL 15550601 A IL15550601 A IL 15550601A IL 15550601 A IL15550601 A IL 15550601A IL 155506 A0 IL155506 A0 IL 155506A0
Authority
IL
Israel
Prior art keywords
chemically synthesized
folding
synthesized polypeptides
cysteine
reducing agent
Prior art date
Application number
IL15550601A
Other languages
English (en)
Original Assignee
Rmf Dictagene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rmf Dictagene Sa filed Critical Rmf Dictagene Sa
Publication of IL155506A0 publication Critical patent/IL155506A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL15550601A 2000-11-27 2001-11-27 Process for folding chemically synthesized polypeptides IL155506A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00204207 2000-11-27
PCT/EP2001/014163 WO2002050099A2 (en) 2000-11-27 2001-11-27 Process for folding chemically synthesized polypeptides

Publications (1)

Publication Number Publication Date
IL155506A0 true IL155506A0 (en) 2003-11-23

Family

ID=8172340

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15550601A IL155506A0 (en) 2000-11-27 2001-11-27 Process for folding chemically synthesized polypeptides

Country Status (22)

Country Link
US (2) US20020082384A1 (xx)
EP (2) EP1337549B1 (xx)
JP (1) JP2004516300A (xx)
KR (1) KR20030081315A (xx)
CN (2) CN1830999A (xx)
AT (1) ATE322501T1 (xx)
AU (2) AU2002229603B2 (xx)
BR (1) BR0113091A (xx)
CA (1) CA2416054A1 (xx)
CU (1) CU23034A3 (xx)
DE (1) DE60118598T2 (xx)
DK (1) DK1337549T3 (xx)
ES (1) ES2261509T4 (xx)
HU (1) HUP0302395A3 (xx)
IL (1) IL155506A0 (xx)
MX (1) MXPA03003576A (xx)
NO (1) NO20032356D0 (xx)
NZ (1) NZ523679A (xx)
PL (1) PL364932A1 (xx)
RU (1) RU2275377C2 (xx)
WO (1) WO2002050099A2 (xx)
ZA (1) ZA200300642B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091310B2 (en) * 2002-09-13 2006-08-15 Chemokine Therapeutics Corporation Chemokine analogs for the treatment of human disease
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
MXPA05010773A (es) 2003-04-09 2005-12-12 Neose Technologies Inc Metodos de glicopegilacion y proteinas/peptidos producidos por los metodos.
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
JP2008529969A (ja) * 2004-10-26 2008-08-07 ロンザ ア−ゲ− 固相合成におけるｓ−アルキル−スルフェニル保護基
JP5948627B2 (ja) 2004-10-29 2016-07-20 レイショファーム ゲーエムベーハー 線維芽細胞成長因子（ｆｇｆ）のリモデリングと糖質ペグ化
EP1858543B1 (en) 2005-01-10 2013-11-27 BioGeneriX AG Glycopegylated granulocyte colony stimulating factor
US20070154992A1 (en) 2005-04-08 2007-07-05 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
EP1893632B1 (en) * 2005-06-17 2015-08-12 Novo Nordisk Health Care AG Selective reduction and derivatization of engineered factor vii proteins comprising at least one non-native cysteine
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
US20090081145A1 (en) * 2005-12-23 2009-03-26 Aplagen Gmbh Process for forming disulphide bridges
CA2651070A1 (en) * 2006-05-03 2007-11-15 Mallinckrodt Inc. Composition and method for the release of protected peptides from a resin
CN101516388B (zh) 2006-07-21 2012-10-31 诺和诺德公司 通过o-联糖基化序列的肽的糖基化
EP2054521A4 (en) 2006-10-03 2012-12-19 Novo Nordisk As METHODS OF PURIFYING CONJUGATES OF POLYPEPTIDES
EP2125863A1 (de) * 2006-12-23 2009-12-02 AplaGen GmbH Verfahren zur ausbildung von disulfidbrücken
RS52845B (en) 2007-04-03 2013-12-31 Biogenerix Ag TREATMENT PROCEDURES USING GLYCOPEGILATED G-CSF
US9493499B2 (en) 2007-06-12 2016-11-15 Novo Nordisk A/S Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography
EP2257311B1 (en) 2008-02-27 2014-04-16 Novo Nordisk A/S Conjugated factor viii molecules
CN104844693B (zh) * 2015-06-10 2018-08-03 成都圣诺生物科技股份有限公司 一种合成利那洛肽的方法
CN111655314B (zh) 2018-02-02 2022-11-18 诺和诺德股份有限公司 具有可偏转换能器的药物注射装置
CN111100188A (zh) * 2018-10-25 2020-05-05 成都医学院 一种制备蜘蛛抗菌肽的方法
CN109593119A (zh) * 2019-01-27 2019-04-09 上海丽珠制药有限公司 一种[2-d-组氨酸]-醋酸亮丙瑞林的制备方法
JP7453745B2 (ja) * 2019-03-28 2024-03-21 株式会社ヤクルト本社 毒性タンパク質の活性を阻害するペプチドのスクリーニング方法及び毒性タンパク質の製造方法
CN110845595A (zh) * 2019-11-14 2020-02-28 连云港职业技术学院 一种固相合成5-tmara标记的铁调素-25的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
DE3236849A1 (de) * 1982-10-05 1984-04-05 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue thiohydrazin-1,2-dicarbonsaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung
IL96682A0 (en) * 1989-12-15 1991-09-16 Amgen Inc Production of biologically active platelet-derived growth factor from high expression host cell systems
CA2072249C (en) * 1991-06-28 2003-06-17 Saiko Hosokawa Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
CN1105029A (zh) * 1993-05-24 1995-07-12 花王株式会社 制备溶解蛋白质的方法
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
DE4431317A1 (de) * 1994-09-02 1996-03-07 Biotechnolog Forschung Gmbh Schutz- bzw. Ankergruppen und deren Verwendung

Also Published As

Publication number Publication date
ES2261509T4 (es) 2008-02-16
AU2960302A (en) 2002-07-01
DE60118598T2 (de) 2007-02-15
US20050239162A1 (en) 2005-10-27
MXPA03003576A (es) 2003-10-14
DK1337549T3 (da) 2006-07-31
CU23034A3 (es) 2005-03-22
RU2275377C2 (ru) 2006-04-27
US20020082384A1 (en) 2002-06-27
CN1449406A (zh) 2003-10-15
CN1249078C (zh) 2006-04-05
EP1337549A2 (en) 2003-08-27
CN1830999A (zh) 2006-09-13
HUP0302395A3 (en) 2007-05-02
WO2002050099A2 (en) 2002-06-27
NO20032356L (no) 2003-05-26
NO20032356D0 (no) 2003-05-26
KR20030081315A (ko) 2003-10-17
NZ523679A (en) 2005-10-28
EP1679318A1 (en) 2006-07-12
EP1337549B1 (en) 2006-04-05
PL364932A1 (en) 2004-12-27
ZA200300642B (en) 2004-07-16
ATE322501T1 (de) 2006-04-15
WO2002050099A3 (en) 2002-09-19
JP2004516300A (ja) 2004-06-03
AU2002229603B2 (en) 2007-11-08
HUP0302395A2 (hu) 2003-10-28
BR0113091A (pt) 2003-07-08
DE60118598D1 (de) 2006-05-18
ES2261509T3 (es) 2006-11-16
CA2416054A1 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
IL155506A0 (en) Process for folding chemically synthesized polypeptides
ATE293159T1 (de) Stabilisierendes verdünnungsmittel für polypeptide und antigene
ATE393576T1 (en) Use of acid-stable subtilisin proteases in animal feed
GEP20053583B (en) Sorbent Composition, Process for Its Production and Use in Desulfurization
IL161016A (en) Polypeptides capable of ang-2 binding
PT1326630E (pt) Utilização de péptidos glp-2
HK1025252A1 (en) Use of exendins and agonists thereof for the reduction of food intake.
DE50103437D1 (de) Künstliches Fingergelenk
IL138608A0 (en) Antibody variants and fragments thereof
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
EP1384778A4 (en) PROTEIN SYNTHESIS METHOD USING ACELLULAR PROTEIN SYNTHESIS SYSTEM
CA2058934A1 (en) Processes for the recovery of microbially produced chymosin
HUT64369A (en) Collagen binding protein and method for producing it
GB0022995D0 (en) Polynucleotide
MXPA04002103A (es) Una proteina de union a caspasa-8, su preparacion y uso.
EP1375502A4 (en) PROCESS FOR PRODUCING 2,6-DIHALOGENOPURIN
DE3852105T2 (de) Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe.
AU2001256315A1 (en) Use of guanylate cyclase-c (gc-c) agonists as insulinotropic factors for treating diabetes type 2
GB0315182D0 (en) Cytokine variant polypeptides
DE69736325D1 (de) Cr1 fragmente und deren verwendung
EP1385979A4 (en) METHOD FOR IMPROVING THE TRANSLATION AND EXPRESSION OF RECOMBINANT PROTEINS
ES1043476U (es) Chapa perfeccinada
MXPA04004303A (es) Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos pai-1.
EP1004596A4 (en) PROTEIN 1 (3) mbt, POLYNUCLEOTIDE ENCODING SAID PROTEIN, ITS ANTISENSE POLYNUCLEOTIDE AND ANTIBODIES RECOGNIZING SAID PROTEIN
ES1035937U (es) Regadera.